West Pharmaceuticals, a pharmaceutical, biopharmaceutical and medical-device company with 50 locations worldwide, plans to invest $29m over the next five years at its Kinston manufacturing plant in North Carolina site.
Subscribe to our email newsletter
The Kinston facility, which manufactures syringe plungers and other components of intravenous (IV) systems, has around 325 workers.
The Lionville, Pennsylvania-based firm intends to upgrade the Kinston plant with latest technologies to meet a growing demand for pharmaceutical products in the region.
West Pharmaceuticals chairman and CEO Don Morel said the choice to go with Kinston was driven by the quality of the local workforce, strong partnerships with state and local government and the geographic area, since Kinston will serve as a backup to a sister plant in Pennsylvania.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.